Specifically, E2F target proteins, MYC targets, and G2/M checkpoint proteins were more abundant, whereas innate immune response proteins reduced upon adaptation to aneuploidy in both model cell lines and malignant tumors. The gene discussed is MYC; the disease is cancer.